These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 4242400

  • 21. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R, Greeff K, Wagner J.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels].
    Fleckenstein A, Grün G, Byon KY.
    Minerva Med; 1975 May 23; 66(38):1827-37. PubMed ID: 1128823
    [Abstract] [Full Text] [Related]

  • 24. [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
    Fleckenstein A.
    Arzneimittelforschung; 1970 Sep 23; 20():Suppl 9a:1317+. PubMed ID: 5536556
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Oxygen uptake and carbon dioxide release by the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W, Meister W, Kriener J.
    Arzneimittelforschung; 1971 Apr 23; 21(4):458-62. PubMed ID: 5108140
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Interactions between beta-adrenolytic agents and narcotics. Experimental research].
    Di Mezza F, Marmo E.
    Minerva Anestesiol; 1970 Mar 03; 36(3):184-92. PubMed ID: 4393055
    [No Abstract] [Full Text] [Related]

  • 30. [Calcium-antagonism, a new principle in coronary vasodilation].
    Grün G, Fleckenstein A.
    Minerva Med; 1975 May 23; 66(38):1838-45. PubMed ID: 805387
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Proceedings: Further studies on the neutralization of glycosine-induced contractures of coronary smooth muscle by Ca-antagonistic compounds (verapamil, D 600, prenylamine, nifedipine, fendiline or nitrites).
    Fleckenstein A, Fleckenstein-Grün G.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 May 23; 287 Suppl():R38. PubMed ID: 1143432
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Studies on the mechanism of action of prenylamine].
    Lindner E.
    Arzneimittelforschung; 1969 Jan 23; 19(1):15-9. PubMed ID: 5819360
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effects of anti-anginal drugs on AV-conduction in normal subjects.
    Neuss H, Nowak FG, Schlepper M, Wüsten B.
    Arzneimittelforschung; 1974 Feb 23; 24(2):213-6. PubMed ID: 4150916
    [No Abstract] [Full Text] [Related]

  • 40. [Metabolic effects of various palliative drugs for coronary insufficiency].
    Deltour G.
    Therapie; 1970 Feb 23; 25(2):293-322. PubMed ID: 4404034
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.